Rheumatologists seek to reassure amid hydroxychloroquine shortage
March 26, 2020
Rheumatologists Jill P. Buyon and Peter M. Izmirly answer questions about the availability of hydroxychloroquine during the COVID-19 pandemic, and rheumatologist Michael H. Pillinger discusses the prospects for a new trial of the gout drug colchicine in COVID-19 patients.
Large population-based study underscores link between gout, CVD event risk
November 23, 2019
ATLANTA – The relationships between gout and fatal and nonfatal CVD events found in a large population-based health data linkage study in New Zealand were not ameliorated by allopurinol use or serum urate lowering to treatment target.
Almost one-third of ED patients with gout are prescribed opioids
July 3, 2019
A diagnosis of diabetes or polyarticular gout attack, and prior opioid use were all associated with a more than 100% higher odds of opioid prescription.